We combine classical genetics with modern technology to understand human physiology and search for breakthrough treatments for diseases.

The Rohatgi Lab focuses on the role of reverse cholesterol transport in atheroprotection.

Dr. Garg's research focuses on diabetes, insulin resistance, and disorders of adipose tissue.

The Marciano laboratory investigates fundamental aspects of kidney development and regeneration, in both health and disease.

We study bacterial colonization of the intestinal tract, to understand how both benign and pathological bacteria affect their environment. Our long-term goal is to treat intestinal diseases by genetically engineering bacteria in vivo.

The James Kim Lab examines the communication between epithelia and stroma through the lens of fundamental developmental pathways such as Hedgehog, Wnt, and Notch pathways.

Discover the Miguel Vazquez Lab at UT Southwestern, leading research in chronic kidney disease, diabetes, and hypertension. Learn about the IDC-Pieces study—a large, NIH-supported clinical trial improving chronic disease management through innovative care models and technology.

The Reinecker laboratory unravels and targets molecular mechanisms of key human genetic variants that cause chronic inflammatory diseases and cancer by creating novel genetic mouse and human organotypic model systems.

My research interests include prevention of progression of renal diseases, diagnoses, and management of lipid disorders in renal disease, hypertensive nephrosclerosis, the role of angiotensin II converting enzyme inhibitors, and angiotensin II receptor blockers in renal disease. 

The Saxena lab's research interests include Icodextin in high peritoneal transporters; Kremezin study in patients with chronic kidney disease; SV40 in focal segmental glomerulosclerosis; molecular studies in lupus nephritis.